Science & medicine news
-
Detect minor clones in blood cells: St. Jude looks deep to find source of accelerated aging in childhood cancer survivors
Explore how deep sequencing childhood cancer survivors found the mutational fingerprint of a toxic chemotherapy associated with a marker of accelerated aging.
-
St. Jude scientists create more efficient CAR immunotherapies using a molecular anchor
Discover how chimeric antigen receptors (CARs) with a new anchor domain increased anti-cancer activity of cellular immunotherapies in cancer models.
-
Thirumala-Devi Kanneganti, Ph.D. named 2022 AAAS Fellow
Immunologist recognized for her achievements in innate immunity, developing new concepts in inflammasome biology, inflammatory cell death.
-
Catherine Corbin named chief business innovation officer at St. Jude
Expert in human-centered design to lead new St. Jude department focused on advancing strategic plan.
-
St. Jude names leading researcher as new chair of oncology department
Julie R. Park, M.D., to succeed longtime chair Ching-Hon Pui, M.D.
-
Pioneering approach advances study of CTCF protein in transcription biology
Scientists at St. Jude used an innovative degradation system on CTCF, learning more about this protein’s role in transcription. Read about the findings.